We are live on
!
Find out more
IPC
Invesco Private Capital Portfolio holdings
AUM
$365M
1-Year Est. Return
8.08%
This Fund
S&P 500
This Quarter
Est. Return
+20.71%
1 Year Est. Return
-8.08%
3 Year Est. Return
+41.89%
5 Year Est. Return
-16.05%
10 Year Est. Return
–
AUM
$459M
AUM Growth
+$75.8M
(+20%)
Cap. Flow
+$5.05M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twilio
TWLO
|
+$5.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xenon Pharmaceuticals
XENE
|
+$94.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 54.02% |
| 2 | Financials | 44.44% |
| 3 | Technology | 0.86% |
| 4 | Healthcare | 0.67% |
Similar funds
AEPG
AR
LCM
WIM
COI
GWA
NC
KCM
Invesco Private Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Invesco Private Capital held 6 positions worth $459M, up 20% from $383M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Invesco Private Capital's Q4 2016 filing shows 1 new and 1 reduced positions. Its largest new stake was Twilio: 137,381 shares worth $3.96M. The largest sale was Xenon Pharmaceuticals, an estimated $94.8K.
By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 55% a quarter earlier, followed by Financials and Technology.
- Invesco Private Capital's largest Q4 2016 buy was Twilio: 137,381 shares worth $3.96M.
- Invesco Private Capital's biggest Q4 2016 reduction was Xenon Pharmaceuticals, cutting an estimated $94.8K.
- Invesco Private Capital's ten largest holdings make up 100% of its $459M portfolio in Q4 2016.
- Invesco Private Capital opened 1 new position and closed 0 in Q4 2016.
- Invesco Private Capital's portfolio value rose 20% quarter-over-quarter to $459M.
Based on Invesco Private Capital's 13F filing for Q4 2016, filed 14 Feb 2017.